SAN FRANCISCO, Nov. 14, 2018 /PRNewswire-PRWeb/ -- Medrio, the leading provider of transformational eClinical technology
"Connecting face-to-face with researchers is an invaluable way to understand their needs, whether pertaining to eClinical technology or business development," commented Mike Novotny, founder and CEO of Medrio. "PCT Europe is a great chance to solidify our Customer First principle in Europe and form new collaborations with companies doing fascinating things in clinical research."
Medrio is rapidly expanding its footprint in the European clinical research market. The company has stationed Business Development, Support, and Customer Success staff across Europe to address the needs and facilitate the success of new and existing European customers. Participation in Partnerships in Clinical Trials Europe represents another milestone to further assert Medrio's presence and establish new connections with European contract research organizations (CROs). The company's representatives present at the conference will be available for private meetings to discuss the significant benefits for CROs of partnering with Medrio, which include:
To learn more about this partnership strategy, interested parties can book a private meeting with a Medrio representative by contacting Nathan Waller, Managing Director, EMEA at Medrio, at nwaller(at)medrio(dot)com.
After expanding significantly in Europe over the last year, Medrio currently provides its services to a multitude of European organizations, largely CROs, conducting clinical trials in a wide array of areas including pharmaceuticals, medical devices, diagnostics, and others. "Europe-based clients are already enjoying the benefits Medrio brings to their business, and we're delighted to be part of the PCT Europe conference for the first time." commented Mr. Waller. "My team and I look forward to meeting old friends and making new ones to explore together the future of clinical research and grow their businesses."
About Medrio Medrio is the leading provider of eClinical technology for clinical trials. Founded in 2005, Medrio's cloud-based EDC, eSource, eConsent, and ePRO solutions deliver innovative and easy-to-use tools for the collection and management of clinical data and patient reported outcome responses. Study sponsors and contract research organizations have used Medrio extensively in clinical trials across a wide array of therapeutic areas, with notable success in oncology, infectious disease, and more. Medrio has extensive experience in all study phases and leads the market in early-phase trials. The company serves over 500 customers globally, with headquarters in San Francisco and offices in numerous domestic and international locations. For more information, please visit http://www.medrio.com.
Subscribe to our Free Newsletters!